Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. - sprookjes - yvandenbroek - TriplyDB

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.

http://www.wikidata.org/entity/Q36108048

about

Endogenous and Exogenous Stem/Progenitor Cells in the Lung and Their Role in the Pathogenesis and Treatment of Pediatric Lung Disease Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges Stem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary Dysplasia An update on pharmacologic approaches to bronchopulmonary dysplasia Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later Life Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.Diffuse lung disease in children: summary of a scientific conference.MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.Animal models of bronchopulmonary dysplasia. The term mouse models The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.Pulmonary hypertension in bronchopulmonary dysplasia The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice Mesenchymal stem cell-conditioned media suppresses inflammation-associated overproliferation of pulmonary artery smooth muscle cells in a rat model of pulmonary hypertension.CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation.Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia Hyperoxia-induced hypertrophy and ion channel remodeling in left ventricle Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disea Role of microRNAs in lung development and pulmonary diseases Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012 N-methyl-D-aspartate receptor activation mediates lung fibroblast proliferation and differentiation in hyperoxia-induced chronic lung disease in newborn rats.Stem cell-based therapy for neonatal lung disease: it is in the juice.Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.Mesenchymal stem cells and the lung.Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia.Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases.Mesenchymal stem cell trials for pulmonary diseases.Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.Prospects and progress in cell therapy for acute respiratory distress syndrome.Cell-based therapies for neonatal lung disease.Preclinical evaluation of cell-based strategies to prevent or treat bronchopulmonary dysplasia in animal models: a systematic review.

P2860

Q26752355-CAB00A05-205A-4125-84A2-3808A1F2F009 Q26771562-364849B4-409D-4A93-AA9E-2D9B8D801BCB Q26797261-5D424A36-BD18-4A9E-BC74-A1F3D09A2444 Q26825139-59F0F3E8-F774-41FB-BCD3-4890B3740169 Q26860314-F26885D7-14A9-4B05-BE42-BABF5EE46660 Q27009438-655B705A-F15F-474B-B426-8606E40A2068 Q28393759-7B5D2D2A-65C5-438C-A25D-F2146C7AC854 Q33722466-18DC3418-DDCC-476D-89A4-0592A5579F8F Q34094344-2A0943D7-CBC5-4CD3-ABBD-A33DEB630A31 Q34370097-CF4ACB56-523E-4EBB-B7FB-FDAC816F0676 Q34726840-9E4FADF0-444E-40CF-AB81-8E3B07A1503C Q34782558-AA9EB337-F289-4B5E-80AB-A3EB4B3D5DBD Q35084278-724AC837-E73E-4B86-ADFB-EF10E9CB3BE8 Q35553636-5A3994B6-6B49-48ED-9000-12EE603E58DA Q35731631-A430A8A4-5ACC-446A-8A46-A857A2A7A758 Q36155476-45BE3D34-4EEB-4E9D-ACB6-2C42C980FCEE Q36212633-90F2B4BC-95D7-4A5A-B563-138EC821348A Q36524066-32C53228-3CB1-48EE-AE9E-69DCDDDDE7BE Q36703006-E87B4D76-D18C-4E9E-BA87-93AB9512D608 Q36841101-5CC7F557-DB21-4F05-B4F4-28E462821794 Q36923943-20265343-DC93-45E4-8A70-62A12A6B2302 Q37109084-E60D9234-AD7D-464A-93A7-5A3E0E2C77C5 Q37133793-51F3E9CD-E39D-4277-A21B-0F3513F3D1AA Q37186946-813FC9FC-26A3-4539-9D05-1A9FA4274615 Q37358867-70260E40-1449-418C-94B0-B63518C9A730 Q37613823-DFD06D7E-B511-4F88-8639-BCBF4543D960 Q37614303-E58A7791-244D-42AF-8A23-E7D74DF4AA8A Q37651549-567DA13C-8586-4F20-A0B9-FAD0D70D9173 Q37691577-A1A6BD2D-97AD-4E03-B1A0-C2187363AAF5 Q37723306-CE694F5E-AC8C-484F-BA42-8D41050D0A60 Q38073795-DD3D7122-BEE5-418E-AB4F-AF8A8BD0766C Q38099709-5BD580EF-541C-4316-AB3F-0640B8690C17 Q38161431-5EA7FAD2-4132-4457-8EBF-3F6AB7F85E9B Q38165146-DA4C3666-AA6A-49D9-9747-CB3325813400 Q38187078-D57F24E5-8D60-44B7-ABDE-3C860054A905 Q38632257-6230AC39-1CAF-4FC1-AFAE-DF633EFC7825 Q38832703-265B65BC-5365-4045-9188-88EB9B8F24B4 Q38917280-3849CBA4-9CE9-44EA-BA66-DF9650B5D5B1 Q38988029-7FEB4B63-3978-493A-ABBD-4A219D3251D2 Q39170971-B73117A6-FDD7-4116-830C-A3E2D9EDC45C

P2860

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.

http://www.wikidata.org/entity/Q36108048

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Mesenchymal stem cell-mediated ...... ciated pulmonary hypertension.

@ast

Mesenchymal stem cell-mediated ...... ciated pulmonary hypertension.

@en

type

label

Mesenchymal stem cell-mediated ...... ciated pulmonary hypertension.

@ast

Mesenchymal stem cell-mediated ...... ciated pulmonary hypertension.

@en

prefLabel

Mesenchymal stem cell-mediated ...... ciated pulmonary hypertension.

@ast

Mesenchymal stem cell-mediated ...... ciated pulmonary hypertension.

@en

P1433

Q36108048-54D530B3-DFAA-46F8-86D1-236F1EAF3860

P1476

Q36108048-9ACD5B87-FF1A-40ED-981F-348208562F1D

P2093

Q36108048-160C1F79-07DC-4B72-A4D0-F089EE60065E

Q36108048-260CC0F7-E645-4217-A371-6F8E1481F828

Q36108048-3CFFF44A-3F4B-430F-9C7B-92CA797C4E1C

Q36108048-622162B4-2217-461F-81A0-FDE5B9B3D977

Q36108048-97E322CD-2945-45A8-AF7B-C33D8211BF71

Q36108048-E3F0A61F-AC9E-49C4-8A24-B633C0447FB0

P2860

Q36108048-0BE795B4-2BB4-49B9-8CFA-3426915DF492

Q36108048-0FD07B03-5D2A-42D2-B8AA-37DC649B8F0C

Q36108048-135CE4E0-74C0-49C3-BA2A-23A83D60A68A

Q36108048-1520E1FC-145B-4774-A02A-FFD16BEEF9BB

Q36108048-1711F280-F3A1-409C-AF7D-90B765272394

Q36108048-2547FA87-279E-4988-86EB-B39CE3F0F5E5

Q36108048-2A166FC1-6A8C-4E8C-BE39-10FF6BEDE8CD

Q36108048-2A7314A6-50CA-4378-9944-8FB5F818F808

Q36108048-2AAD298E-B73A-4FC5-9C00-9E768ABED045

Q36108048-32875FB5-6D2B-4744-9FF6-C8ED90A405A8

P304

Q36108048-05C3F8B6-D9DB-4301-B125-06452F38488A

P31

Q36108048-2EA8B2AC-82CF-4A10-9E05-4E21F7974645

P356

Q36108048-EFAC4D57-31CD-4F82-B6B2-0C78101D2059

P433

Q36108048-5BC89CA1-ECE1-406C-9D23-7EF5ABF6BCC4

P478

Q36108048-585347E0-F017-4FE1-A61F-EF0AD9A29DC7

P50

Q36108048-21470F36-AD75-482F-846E-C50F23F38E34

P577

Q36108048-608840B0-C5BF-4E14-9E27-B01DDAA6F637

P5875

Q36108048-1ADB8CD6-8DE0-4B6D-B921-353A01A95E50

P698

Q36108048-FA2AECBA-7167-455A-8510-30181E21DF18

P921

Q36108048-EDB0417A-2289-4F94-BC57-DA94D68182ED

P932

Q36108048-BA6717C3-9D40-49F9-9827-B8F5934CE4EB

P356

2045-8932.97603

P1433

Pulmonary circulation

P1476

Mesenchymal stem cell-mediated ...... ociated pulmonary hypertension

@en

P2093

Angeles Fernandez-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Georg Hansmann

http://www.w3.org/2001/XMLSchema#string

Muhammad Aslam

http://www.w3.org/2001/XMLSchema#string

Sally H Vitali

http://www.w3.org/2001/XMLSchema#string

Stella Kourembanas

http://www.w3.org/2001/XMLSchema#string

Thomas Martin

http://www.w3.org/2001/XMLSchema#string

P2860

WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

A perivascular origin for mesenchymal stem cells in multiple human organs

Bronchopulmonary dysplasia

Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae.

Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.

Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells.

P304

170-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2045-8932.97603

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

S. Alex Mitsialis

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230574421

http://www.w3.org/2001/XMLSchema#string

P698

22837858

http://www.w3.org/2001/XMLSchema#string

P921

bronchopulmonary dysplasia

P932

3401871

http://www.w3.org/2001/XMLSchema#string